Chemed Corporation (NYSE:CHE - Get Free Report) shares hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $468.30 and last traded at $472.44, with a volume of 6237 shares. The stock had previously closed at $473.18.
Analyst Ratings Changes
CHE has been the topic of several recent research reports. Wall Street Zen cut shares of Chemed from a "buy" rating to a "hold" rating in a research note on Saturday. Bank of America reduced their price target on Chemed from $708.00 to $650.00 and set a "buy" rating on the stock in a report on Monday, June 30th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and set a $640.00 price target (down previously from $674.00) on shares of Chemed in a report on Monday, June 30th.
Get Our Latest Stock Report on CHE
Chemed Trading Down 2.5%
The firm has a market cap of $6.75 billion, a PE ratio of 22.46, a price-to-earnings-growth ratio of 2.28 and a beta of 0.50. The firm has a fifty day moving average price of $555.54 and a 200 day moving average price of $563.17.
Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.59 by $0.04. The firm had revenue of $646.94 million for the quarter, compared to analyst estimates of $641.78 million. Chemed had a net margin of 12.40% and a return on equity of 27.58%. Chemed's revenue was up 9.8% on a year-over-year basis. During the same period in the previous year, the firm earned $5.20 EPS. As a group, equities analysts predict that Chemed Corporation will post 21.43 earnings per share for the current year.
Chemed Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.43%. The ex-dividend date was Thursday, May 29th. Chemed's dividend payout ratio is currently 9.74%.
Insider Activity
In related news, EVP Spencer S. Lee sold 1,500 shares of the company's stock in a transaction that occurred on Friday, May 16th. The shares were sold at an average price of $577.99, for a total transaction of $866,985.00. Following the sale, the executive vice president directly owned 14,627 shares in the company, valued at approximately $8,454,259.73. This represents a 9.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 1,500 shares of the company's stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $576.45, for a total transaction of $864,675.00. Following the sale, the chief executive officer owned 101,197 shares in the company, valued at $58,335,010.65. The trade was a 1.46% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 4,500 shares of company stock valued at $2,598,450. 3.29% of the stock is currently owned by corporate insiders.
Institutional Trading of Chemed
A number of large investors have recently made changes to their positions in CHE. Alpine Bank Wealth Management acquired a new position in Chemed in the first quarter valued at approximately $29,000. HM Payson & Co. acquired a new position in Chemed in the first quarter valued at approximately $30,000. SVB Wealth LLC acquired a new position in Chemed in the first quarter valued at approximately $30,000. Whipplewood Advisors LLC boosted its holdings in Chemed by 54.5% in the first quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock valued at $31,000 after purchasing an additional 18 shares in the last quarter. Finally, WPG Advisers LLC acquired a new position in Chemed in the first quarter valued at approximately $32,000. 95.85% of the stock is currently owned by hedge funds and other institutional investors.
Chemed Company Profile
(
Get Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Read More
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.